Feature | June 02, 2014

St. Jude Medical Completes Acquisition of CardioMEMS

June 2, 2014 — St. Jude Medical announced the completion of its acquisition of the privately held CardioMEMS Inc., developer of the CardioMEMS heart failure (HF) management system. The acquisition was completed on May 30, 2014.

“St. Jude Medical’s acquisition of CardioMEMS shows our commitment to providing innovative medical device solutions that reduce the burden of complex diseases like heart failure, both on patients and healthcare systems. The CardioMEMS HF system achieves this goal by setting a new treatment paradigm for heart failure that reduces hospitalizations and improves the quality of life for patients,” said Daniel J. Starks, chairman, president and CEO of St. Jude Medical.

The CardioMEMS HF system is the first and only U.S. Food and Drug Administration (FDA)-approved heart failure monitoring device proven to significantly reduce hospital admissions when used by physicians to manage heart failure. St. Jude Medical will now begin its strategic launch of the CardioMEMS HF system in the United States.

The CardioMEMS HF system allows clinicians to stabilize pulmonary artery pressures by proactively managing medications and other treatment options while also providing an early indication of worsening heart failure, thereby improving heart failure patients’ quality of life, and reducing economic risks for hospitals and payers.

Bank of America Merrill Lynch acted as financial advisor and Gibson, Dunn & Crutcher LLP as legal counsel to St. Jude Medical. J.P. Morgan Securities LLC acted as financial advisor to CardioMEMS and Cooley LLP as legal counsel.

For more information: www.sjm.com

Related Content

heart failure, muscle bleeding, British Cardiovascular Conference, MRI
News | Heart Failure| June 08, 2016
The amount a heart ‘bleeds’ following a heart attack can predict the severity of future heart failure, according to...
CardioMEMS HF, heart failure patients, European Society of Cardiology guidelines
News | Heart Failure| June 07, 2016
St. Jude Medical Inc. announced that its CardioMEMS HF System was added to the European Society of Cardiology (ESC)...
CardioMEMS, heart failure, PA pressure monitoring

The CardioMEMS device detects worsening heart failure symptoms using pulmonary artery pressure monitoring. Pressure increases can indicate early signs of fluid backup so physicians can make changes to the patient's medications and prevent an acute congestive heart failure hospital admission. 

Feature | Heart Failure| June 01, 2016 | Jeff Zagoudis
Healthcare reform efforts of recent years have challenged the industry to reduce the costs of healthcare for both pat
BioVentrix, Revivent-TC System, heart failure, ALIVE U.S. clinical trial, FDA IDE
News | Heart Failure| June 01, 2016
BioVentrix Inc. announced that it has received a U.S. Food and Drug Administration (FDA) Investigational Device...
Corsens Cardiac Monitor, FDA 510k pre-market notification
News | Patient Monitors| May 26, 2016
Corsens Medical Ltd. announced it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the U...
News | Stem Cell Therapies| May 26, 2016
May 26, 2016 — Ligand Pharmaceuticals Inc.
Ambio Health telemonitoring system, LifeBridge Health Cardiovascular Institute, Baltimore, pilot study
News | Remote Monitoring| May 26, 2016
The LifeBridge Health Cardiovascular Institute, Baltimore, has launched a pilot study to evaluate the potential...
cardiac rehab, cardiac rehabilitation, CHF, heart failure

Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. Patient engagement is key to improving CHF patient quality of life and outcomes without the use of drugs and devices.

Feature | Cardiac Rehabilitation| May 24, 2016 | Karen D. Walker, RN, MSN, and Stephanie Rejc, MS
Cardiac rehabilitation and exercise training has been shown to improve clinical status and outcomes in congestive hea
News | Heart Failure| May 23, 2016
May 23, 2016 — In a guideline update published last week, the American College of Cardiology, American Heart Associat
Bioventrix, Revivent-TC System, heart failure, first-in-man procedure
News | Heart Failure| May 19, 2016
BioVentrix announced the first-in-man use of its next-generation Revivent-TC System with an endovascular catheter-based...
Overlay Init